Gå frakoblet med Player FM -appen!
Eli Lilly + Innovent Biologics, Agios, TC Biopharm, Blue Water Vaccines, Meihua
Manage episode 321061628 series 2833924
The PD1 that lost, biopharma earns FDA approval, and the Biotech market is cool not dead
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Eli Lilly + Innovent Biologics
Agios
TC Biopharm
Blue Water Vaccines
Meihua
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
72 episoder
Manage episode 321061628 series 2833924
The PD1 that lost, biopharma earns FDA approval, and the Biotech market is cool not dead
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Eli Lilly + Innovent Biologics
Agios
TC Biopharm
Blue Water Vaccines
Meihua
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
72 episoder
모든 에피소드
×Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.